Literature DB >> 36190593

A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).

Sana Siddiqui1, Somaiya Mateen1, Rizwan Ahmad1, Shagufta Moin2.   

Abstract

Polycystic ovarian syndrome (PCOS) is a prevailing endocrine and metabolic disorder occurring in about 6-20% of females in reproductive age. Most symptoms of PCOS arise early during puberty. Since PCOS involves a combination of signs and symptoms, thus it is considered as a heterogeneous disorderliness. The most accepted diagnostic criteria is Rotterdam criteria which involves two of the latter three features: (a) hyperandrogenism, (b) oligo- or an-ovulation, and (c) polycystic ovaries. The persistent hormonal imbalance leads to multiple small antral follicles formation and irregular menstrual cycle, ultimately causing infertility among females. Insulin resistance, cardiovascular diseases, abdominal obesity, psychological disorders, infertility, and cancer are also related to PCOS. These pathophysiologies associated with PCOS are interrelated with each other. Hyperandrogenism causes insulin resistance and hyperglycemia, leading to ROS formation, oxidative stress, and abdominal adiposity. In consequence, inflammation, ROS production, insulin resistance, and hyperandrogenemia also increase. Elevation of AGEs in the body either produced endogenously or consumed from diet exaggerates PCOS symptoms and is also related to ovarian dysfunction. This review summarizes how AGE formation, inflammation, and oxidative stress are significantly essential in PCOS progression. Alterations during prenatal development like exposure to excess AMH, androgens, or toxins (bisphenol-A, endocrine disruptors, etc.) may also be the etiologic mechanism behind PCOS. Although the etiology of this disorder is unclear, environmental and genetic factors are primarily involved. Physical inactivity, as well as unhealthy eating habits, has a vital role in the progression of PCOS. This review outlines a collection of specific genes phenotypically linked with PCOS. Furthermore, beneficial effect of metformin in maintaining endocrine abnormalities and ovarian function is also mentioned. Kisspeptin is a protein which helps in onset of puberty and increases GnRH pulsatile release during ovulation as well as role of KNDy neurons in GnRH pulsatile signal required for reproduction are also elaborated. This review also focuses on the immunology related to PCOS involving chronic low-grade inflammation, and how the alterations within the follicular microenvironment are intricated in the development of infertility in PCOS patients. How PCOS develops following antiepileptic and psychiatric medication is also expanded in this review. Initiation of antiandrogen treatment in early age (≤ 25 years) might be helpful in spontaneous conception in PCOS women. The role of BMP (bone morphogenetic proteins) in folliculogenesis and their expression in oocytes and granulosa cells are also explained. GDF8 and SERPINE1 expression in PCOS is given in detail.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  AMH; Advanced glycation end products (AGEs); Antiandrogen treatment; BMP (bone morphogenetic proteins); Chronic low-grade inflammation; GDF8; Genetics; Hyperandrogenism; Insulin resistance; Kisspeptin; Metformin; Oxidative stress; Polycystic ovarian syndrome; SERPINE1

Year:  2022        PMID: 36190593     DOI: 10.1007/s10815-022-02625-7

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  135 in total

Review 1.  Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health.

Authors:  Daniel A Dumesic; David R Meldrum; Mandy G Katz-Jaffe; Rebecca L Krisher; William B Schoolcraft
Journal:  Fertil Steril       Date:  2014-12-10       Impact factor: 7.329

Review 2.  Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome.

Authors:  Mark O Goodarzi; Ricardo Azziz
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2006-06       Impact factor: 4.690

Review 3.  Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought.

Authors:  Jason Bronstein; Sonali Tawdekar; Yinghua Liu; Melissa Pawelczak; Raphael David; Bina Shah
Journal:  J Pediatr Adolesc Gynecol       Date:  2011-02       Impact factor: 1.814

4.  Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome.

Authors:  S Kirchengast; J Huber
Journal:  Hum Reprod       Date:  2001-06       Impact factor: 6.918

Review 5.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

Review 6.  Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.

Authors:  Mora Murri; Manuel Luque-Ramírez; María Insenser; Miriam Ojeda-Ojeda; Hector F Escobar-Morreale
Journal:  Hum Reprod Update       Date:  2013-01-09       Impact factor: 15.610

Review 7.  The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance.

Authors:  Adam H Balen; Lara C Morley; Marie Misso; Stephen Franks; Richard S Legro; Chandrika N Wijeyaratne; Elisabet Stener-Victorin; Bart C J M Fauser; Robert J Norman; Helena Teede
Journal:  Hum Reprod Update       Date:  2016-08-10       Impact factor: 15.610

8.  Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality.

Authors:  Yue Liu; Zhiheng Yu; Shigang Zhao; Lei Cheng; Yuanyuan Man; Xueying Gao; Han Zhao
Journal:  J Assist Reprod Genet       Date:  2020-11-20       Impact factor: 3.412

9.  Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index.

Authors:  Melania Manco; Lidia Castagneto-Gissey; Eugenio Arrighi; Annamaria Carnicelli; Claudia Brufani; Rosa Luciano; Geltrude Mingrone
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

Review 10.  Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls.

Authors:  Selma Feldman Witchel; Sharon E Oberfield; Alexia S Peña
Journal:  J Endocr Soc       Date:  2019-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.